Division of General Pediatrics and Adolescent Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
Division of Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Semin Thromb Hemost. 2021 Sep;47(6):623-630. doi: 10.1055/s-0041-1725117. Epub 2021 May 10.
Pediatric venous thromboembolism (VTE) is a condition increasingly encountered by emergency medicine physicians. Unfortunately, despite increased incidence, the diagnosis of pediatric VTE relies on a high index of suspicion from clinicians. Delays in diagnosis and initiation of treatment can lead to poor outcomes in children, including an increased risk of mortality from pulmonary embolism, increased risk of VTE recurrence, and the development of the post-thrombotic syndrome. The majority of pediatric VTE events are associated with the presence of at least one underlying prothrombotic risk. Timely recognition of these risk factors in the emergency department (ED) setting is paramount for a prompt diagnosis and treatment initiation. Compared with children with hospital-acquired VTE, children presenting to the ED with new onset VTE tend to be older (>11 years of age), have a lower incidence of co-morbidities, and present more frequently with a deep venous thrombosis of the lower extremity. Currently, there are no validated pediatric-specific VTE clinical pretest probability tools that reliably assist with the accurate and timely diagnosis of pediatric VTE. Compression ultrasound with Doppler is the most common imaging modality used for VTE diagnosis, and low molecular weight heparins are the most common anticoagulants initiated in children presenting with VTE in the ED. Special consideration should be given to patients who present to the ED already on anticoagulation therapy who may require acute management for clinically-significant bleeding or change in antithrombotic therapy approach for progression/recurrence of VTE.
儿科静脉血栓栓塞症(VTE)是急诊医师越来越常见到的病症。不幸的是,尽管发病率增加,但儿科 VTE 的诊断仍然依赖于临床医生的高度怀疑。诊断和治疗的延迟可能导致儿童预后不良,包括肺栓塞死亡率增加、VTE 复发风险增加以及血栓后综合征的发展。大多数儿科 VTE 事件与至少一种潜在的促血栓形成风险因素有关。在急诊科(ED)环境中及时识别这些危险因素对于及时诊断和治疗启动至关重要。与医院获得性 VTE 相比,在 ED 就诊的新发 VTE 儿童年龄较大(>11 岁),合并症发生率较低,且更常表现为下肢深静脉血栓形成。目前,尚无经过验证的儿科特定 VTE 临床预测概率工具可可靠地协助准确、及时地诊断儿科 VTE。超声检查联合多普勒是用于 VTE 诊断最常用的影像学方法,在 ED 就诊的 VTE 儿童中,最常使用低分子肝素作为起始抗凝药物。对于已经接受抗凝治疗且可能因临床显著出血需要急性处理或因 VTE 进展/复发需要改变抗血栓治疗方法的患者,应给予特别关注。